Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Escalon Medical ( (ESMC) ) has issued an announcement.
On January 23, 2026, Escalon Medical Corp. completed the sale of certain software-related assets tied to its AXIS platform to Scotland-based Optos Public Limited Company under an asset purchase agreement valued at $3 million, structured in three milestone-based payments plus a previously received $25,000 term-sheet payment, and received the first $1 million installment at closing. The company has provided unaudited pro forma condensed consolidated financial statements prepared under SEC rules to show how the disposition would have affected its balance sheet as of September 30, 2025 and its operating results for the three months ended September 30, 2025 and the year ended June 30, 2025, illustrating the expected impact of the transaction on Escalon’s financial profile and signaling a strategic shift away from the divested AXIS software assets toward a more cash-strengthened balance sheet.
More about Escalon Medical
Escalon Medical Corp. is a Pennsylvania-based medical technology company focused on ophthalmic and related healthcare markets, with offerings that include software-enabled platforms such as its AXIS system used in eye-care diagnostics and practice management.
Average Trading Volume: 4,774
Technical Sentiment Signal: Sell
Current Market Cap: $1.16M
See more data about ESMC stock on TipRanks’ Stock Analysis page.